Drug intelligence / Profile preview

Solacid

Development stage
Unknown
Lead developer
Dey's Medical Stores
Modality
Small Molecules
Administration
Oral
01

Overview

Solacid is a marketed fixed-dose combination antacid and anti-flatulent medication developed and manufactured by Dey's Medical Stores. It contains dried aluminium hydroxide, magnesium hydroxide (milk of magnesia), magnesium trisilicate, and simethicone. The antacid components (aluminium hydroxide, magnesium hydroxide, and magnesium trisilicate) work locally in the stomach to neutralize excess gastric acid, thereby raising stomach pH and relieving symptoms of hyperacidity, heartburn, and indigestion. Simethicone acts as a surfactant that reduces the surface tension of gas bubbles in the gastrointestinal tract, facilitating their coalescence and expulsion to relieve bloating and flatulence. Solacid is available in oral tablet and liquid suspension formulations.

Brand names
SolacidSolacid-O
Other names
aluminium hydroxide + magnesium hydroxide + magnesium trisilicate + simethicone
02

Targets

NaV (Voltage-gated sodium channels)PEP (Pepsin)Gas bubbles at the gastrointestinal gas-liquid interface

Beyond the preview

Go deeper on Solacid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solacid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call